Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
With a market cap of 1.54B, Collegium Pharmaceutical(COLL) trades at $47.51. The stock has a price-to-earnings ratio of 29.32.
As of 2026-02-04, Collegium Pharmaceutical(COLL) stock has fluctuated between $47.00 and $48.50. The current price stands at $47.51, placing the stock +1.1% above today's low and -2.0% off the high.
The Collegium Pharmaceutical(COLL)'s current trading volume is 307.34K, compared to an average daily volume of 394.64K.
During the past year, Collegium Pharmaceutical(COLL) stock moved between $23.23 at its lowest and $50.79 at its peak.
During the past year, Collegium Pharmaceutical(COLL) stock moved between $23.23 at its lowest and $50.79 at its peak.
COLL News
Collegium Pharmaceutical recently reported strong past revenue growth of 31.40%, supported by robust demand for its pain management products Xtampza ER and Belb...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.